194 related articles for article (PubMed ID: 31436094)
1. Use of Terahertz-Raman Spectroscopy to Determine Solubility of the Crystalline Active Pharmaceutical Ingredient in Polymeric Matrices during Hot Melt Extrusion.
Bordos E; Islam MT; Florence AJ; Halbert GW; Robertson J
Mol Pharm; 2019 Oct; 16(10):4361-4371. PubMed ID: 31436094
[TBL] [Abstract][Full Text] [Related]
2. Influence of Plasdone
Butreddy A; Sarabu S; Bandari S; Batra A; Lawal K; Chen NN; Bi V; Durig T; Repka MA
AAPS PharmSciTech; 2021 Jun; 22(5):196. PubMed ID: 34184149
[TBL] [Abstract][Full Text] [Related]
3. NMR and Thermal Studies for the Characterization of Mass Transport and Phase Separation in Paracetamol/Copovidone Hot-Melt Extrusion Formulations.
Pisa E; Hughes LP; Wren SAC; Booth J; McCabe JF; Whittaker DTE; Mantle MD
Mol Pharm; 2020 Jun; 17(6):2021-2033. PubMed ID: 32298130
[TBL] [Abstract][Full Text] [Related]
4. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
[TBL] [Abstract][Full Text] [Related]
5. Probing the Molecular-Level Interactions in an Active Pharmaceutical Ingredient (API) - Polymer Dispersion and the Resulting Impact on Drug Product Formulation.
Yang F; Su Y; Small J; Huang C; Martin GE; Farrington AM; DiNunzio J; Brown CD
Pharm Res; 2020 May; 37(6):94. PubMed ID: 32405662
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the Solid Physical State of API and Its Distribution in Pharmaceutical Hot Melt Extrudates Using Terahertz Raman Imaging.
Ibrahim M; Zhang J; Repka M; Chen R
AAPS PharmSciTech; 2019 Jan; 20(2):62. PubMed ID: 30627934
[TBL] [Abstract][Full Text] [Related]
7. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
[TBL] [Abstract][Full Text] [Related]
8. Micro-scale solubility assessments and prediction models for active pharmaceutical ingredients in polymeric matrices.
Bochmann ES; Neumann D; Gryczke A; Wagner KG
Eur J Pharm Biopharm; 2019 Aug; 141():111-120. PubMed ID: 31100430
[TBL] [Abstract][Full Text] [Related]
9. Rheology Guided Rational Selection of Processing Temperature To Prepare Copovidone-Nifedipine Amorphous Solid Dispersions via Hot Melt Extrusion (HME).
Yang F; Su Y; Zhang J; DiNunzio J; Leone A; Huang C; Brown CD
Mol Pharm; 2016 Oct; 13(10):3494-3505. PubMed ID: 27602878
[TBL] [Abstract][Full Text] [Related]
10. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
[TBL] [Abstract][Full Text] [Related]
11. Solubilizing temperature of crystalline drug in polymer carrier: A rheological investigation on a posaconazole-copovidone system with low drug load.
Yang F; Su Y; Brown CD; DiNunzio J
Eur J Pharm Biopharm; 2021 Jul; 164():28-35. PubMed ID: 33895292
[TBL] [Abstract][Full Text] [Related]
12. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug.
Mitra A; Li L; Marsac P; Marks B; Liu Z; Brown C
Int J Pharm; 2016 May; 505(1-2):107-14. PubMed ID: 27012984
[TBL] [Abstract][Full Text] [Related]
13. A systematic and robust assessment of hot-melt extrusion-based amorphous solid dispersions: Theoretical prediction to practical implementation.
Alzahrani A; Nyavanandi D; Mandati P; Youssef AAA; Narala S; Bandari S; Repka M
Int J Pharm; 2022 Aug; 624():121951. PubMed ID: 35753536
[TBL] [Abstract][Full Text] [Related]
14. Chemically identical but physically different: A comparison of spray drying, hot melt extrusion and cryo-milling for the formulation of high drug loaded amorphous solid dispersions of naproxen.
Dedroog S; Huygens C; Van den Mooter G
Eur J Pharm Biopharm; 2019 Feb; 135():1-12. PubMed ID: 30529295
[TBL] [Abstract][Full Text] [Related]
15. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
[TBL] [Abstract][Full Text] [Related]
16. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
[TBL] [Abstract][Full Text] [Related]
17. Real time Raman imaging to understand dissolution performance of amorphous solid dispersions.
Tres F; Treacher K; Booth J; Hughes LP; Wren SA; Aylott JW; Burley JC
J Control Release; 2014 Aug; 188():53-60. PubMed ID: 24910191
[TBL] [Abstract][Full Text] [Related]
18. Development of Amorphous Solid Dispersion Sustained-Release Formulations with Polymer Composite Matrix-Regulated Stable Release Plateaus.
Chen L; Hu E; Shen P; Qian S; Heng W; Zhang J; Gao Y; Wei Y
Pharm Res; 2024 Jun; 41(6):1233-1245. PubMed ID: 38744732
[TBL] [Abstract][Full Text] [Related]
19. Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions.
Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Pharm Res; 2018 Jan; 35(1):25. PubMed ID: 29305717
[TBL] [Abstract][Full Text] [Related]
20. Islatravir Case Study for Enhanced Screening of Thermodynamically Stable Crystalline Anhydrate Phases in Pharmaceutical Process Development by Hot Melt Extrusion.
Skomski D; Varsolona RJ; Su Y; Zhang J; Teller R; Forster SP; Barrett SE; Xu W
Mol Pharm; 2020 Aug; 17(8):2874-2881. PubMed ID: 32511923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
